| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income (loss) | -11,294,490 | -286,905 | -4,780,700 | 728,079 |
| Accounts payable | NaN | NaN | NaN | 4,201,001 |
| Iva receivable and other assets, net | NaN | 722,180 | 16,768 | 483,360 |
| Depreciation and amortization | 410,459 | 327,226 | 279,828 | 559,525 |
| Accretion of asset retirement obligation | 32,514 | 19,483 | 19,482 | 38,967 |
| Noncash operating lease expense | NaN | 0 | 45,032 | 244,510 |
| Share-based compensation | 4,833,965 | 2,392,933 | 3,856,475 | 832,297 |
| Accretion income from investment in debt securities held to maturity | -192,139 | -193,564 | -126,450 | -95,990 |
| Paid-in-kind interest from notes receivable | 45,762 | NaN | NaN | NaN |
| Gain on sale or disposal of property, plant and equipment, net | 1,900 | -60,066 | 8,716 | NaN |
| Other noncash items | NaN | NaN | NaN | 0 |
| Gain on lease termination | NaN | 0 | 469,822 | NaN |
| Equity in losses of joint venture | -16,126 | NaN | NaN | NaN |
| Write-down of inventory to net realizable value | 161,456 | 919,053 | NaN | 0 |
| Change in allowance for credit losses | 156 | -15,054 | 4,914 | 884 |
| Unrealized loss on investment in equity securities | -4,061,430 | 3,321,486 | NaN | NaN |
| Change in iva receivable reserve | NaN | -1,300,620 | NaN | NaN |
| Accounts receivable | -1,700,192 | 2,300,067 | -583,522 | 1,387,733 |
| Royalties payable | NaN | NaN | 24,922 | 49,089 |
| Inventories | 9,666,267 | 5,027,901 | 1,600,634 | 5,566,803 |
| Prepaid expenses and other current assets | 299,710 | -1,442,407 | 477,248 | 1,249,047 |
| Accounts payable | -2,223,094 | 731,891 | 2,672,335 | NaN |
| (gain) loss on sale or disposal of property, plant and equipment, net | NaN | NaN | NaN | -500 |
| Accrued liabilities | 450,368 | 1,222,781 | 329,849 | -175,368 |
| Accrued liabilities - directors | -2,973 | 54,401 | 780 | -52,537 |
| Net cash used in operating activities | -12,059,669 | -3,470,307 | -3,863,700 | -2,356,986 |
| Purchases of investment in debt securities held to maturity | NaN | 19,934,953 | NaN | NaN |
| Purchases of equity investment securities | NaN | 37,172,842 | NaN | NaN |
| Investment in joint venture | 100,000 | NaN | NaN | NaN |
| Purchases of investment securities held to maturity | NaN | NaN | 9,943,694 | 9,991,259 |
| Issuance of note receivable | NaN | 2,500,000 | NaN | NaN |
| Proceeds from note receivable principal payment | 100,000 | NaN | NaN | NaN |
| Proceeds from sales of property, plant and equipment | 1,900 | 4,650 | 8,216 | 500 |
| Proceeds from redemption of certificates of deposit | NaN | NaN | NaN | 0 |
| Purchases of property, plant and equipment | 12,581,587 | 11,739,241 | 8,675,171 | 7,394,073 |
| Net cash used in investing activities | -12,579,687 | -51,407,433 | -18,610,649 | -17,384,832 |
| Principal payments on long-term debt | 33,790 | 33,496 | 33,206 | 65,550 |
| Proceeds from exercises of stock options | 48,624 | 62,667 | 0 | 55,000 |
| Proceeds from exercise of warrants | NaN | NaN | NaN | 2,225,411 |
| Treasury stock acquired | 4,982,634 | 40,229 | 409,246 | NaN |
| Proceeds from issuance of common stock, net of issuance costs | 1,339,446 | 65,770,618 | 33,376,113 | 5,064,483 |
| Proceeds from exercise of warrants | 994,812 | 1,305,175 | 4,427,756 | NaN |
| Net cash (used in) provided by financing activities | -2,633,542 | 67,064,735 | 35,136,006 | 7,279,344 |
| Net (decrease) increase in cash and cash equivalents and restricted cash | -27,272,898 | 12,186,995 | 12,661,657 | -12,462,474 |
| Cash and cash equivalents and restricted cash at beginning of period | 30,657,076 | 18,470,081 | 18,270,898 | NaN |
| Cash and cash equivalents and restricted cash at end of period | 3,384,178 | 30,657,076 | 18,470,081 | NaN |
UNITED STATES ANTIMONY CORP (UAMY)
UNITED STATES ANTIMONY CORP (UAMY)